2021
DOI: 10.1016/j.ypmed.2020.106354
|View full text |Cite
|
Sign up to set email alerts
|

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness

Abstract: The Director-General of the World Health Organization has called for global action towards elimination of cervical cancer as a public health problem. Cervical cancer is caused by human papillomavirus (HPV), an infectious agent with no non-human reservoir. One way to achieve this is through very high levels of vaccine coverage that could enable global eradication of vaccine-type HPV. Using the case study of India, we show that HPV eradication can meet all the Dahlem and Strüngmann criteria for feasibility of er… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 22 publications
(28 reference statements)
0
13
0
Order By: Relevance
“…When examining different vaccination strategies of girls aged 9-14 years, our model predicted that, compared with no vaccination, all vaccination strategies were highly efficient and cost-effective and led to very similar NNVs and ICERs (figure 6; appendix 4 pp [10][11][17][18][19][20]. Nonetheless, our model predicted that routine vaccination of girls aged 14 years, with or without a later switch to routine vaccination of girls aged 9 years, and routine vaccination of girls aged 9 years with an extended interval between doses and catch-up vaccination at age 14 years were the most efficient and cost-effective strategies.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…When examining different vaccination strategies of girls aged 9-14 years, our model predicted that, compared with no vaccination, all vaccination strategies were highly efficient and cost-effective and led to very similar NNVs and ICERs (figure 6; appendix 4 pp [10][11][17][18][19][20]. Nonetheless, our model predicted that routine vaccination of girls aged 14 years, with or without a later switch to routine vaccination of girls aged 9 years, and routine vaccination of girls aged 9 years with an extended interval between doses and catch-up vaccination at age 14 years were the most efficient and cost-effective strategies.…”
Section: Resultsmentioning
confidence: 99%
“…The main difference between HPV-ADVISE LMIC and HPV-ADVISE for HICs is that we included female sex workers and their clients in HPV-ADVISE LMIC because the proportion of men who declare they have paid for sex is higher in some LMICs than in HICs, 17 male clients of female sex workers have been shown to be bridge populations for sexually transmitted infections, 18,19 and female sex workers, as a core group for HPV transmission, might have a role in whether elimination of cervical cancer can be achieved. 20 In HPV-ADVISE LMIC, individuals are attributed one of four mutually exclusive levels of sexual activity: level 0, including women and men who are married and remain married to a single partner throughout their life; level 1, including women who get married and then divorce or whose partner has a concurrent partner during their marriage (excluding female sex workers) and men who get married and then divorce or have a concurrent partnership during their marriage (excluding female sex workers); level 2, including women and men who never get married; and level 3, including female sex workers and men who pay for sex. Notably, men who pay for sex can also have concurrent long-term partnerships with level 0-1 women.…”
Section: Model Structurementioning
confidence: 99%
“…In the era of the COVID-19 pandemic, it may prove extremely difficult to achieve the WHO's goal of eliminating CC as a global public health problem. It is predicted that this goal can be achieved with 90% HPV vaccination coverage in the general population and 95% in high-risk groups [65]. The level of global coverage in 2019 was estimated to be 15% [66].…”
Section: Human Papillomavirus Vaccinationmentioning
confidence: 99%
“…Vaccine cost, inadequate healthcare infrastructure and socio-cultural issues are some of the main reasons for this apparent lack of effectivity. Hence, there is still a pressing need for new and efficient strategies for HPV transmission control, detection and treatment [ 1 , 2 ].…”
Section: Introductionmentioning
confidence: 99%